Annual Cash & Cash Equivalents
$206.53 M
+$186.24 M+917.87%
31 December 2023
Summary:
CymaBay Therapeutics annual cash & cash equivalents is currently $206.53 million, with the most recent change of +$186.24 million (+917.87%) on 31 December 2023. During the last 3 years, it has risen by +$80.73 million (+64.17%).CBAY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$206.53 M
-$67.19 M-24.55%
31 December 2023
Summary:
CymaBay Therapeutics quarterly cash and cash equivalents is currently $206.53 million, with the most recent change of -$67.19 million (-24.55%) on 31 December 2023.CBAY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +64.2% | +64.2% |
| 5 y5 years | +730.5% | +730.5% |
CBAY Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -24.5% |
CymaBay Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $206.53 M(+917.9%) | $206.53 M(-24.5%) |
| Sept 2023 | - | $273.72 M(+671.4%) |
| June 2023 | - | $35.48 M(-40.0%) |
| Mar 2023 | - | $59.15 M(+191.5%) |
| Dec 2022 | $20.29 M(-83.9%) | $20.29 M(-33.9%) |
| Sept 2022 | - | $30.69 M(-41.8%) |
| June 2022 | - | $52.75 M(-28.7%) |
| Mar 2022 | - | $74.00 M(-41.2%) |
| Dec 2021 | $125.81 M(+346.2%) | $125.81 M(+82.4%) |
| Sept 2021 | - | $68.96 M(+109.6%) |
| June 2021 | - | $32.90 M(-24.1%) |
| Mar 2021 | - | $43.33 M(+53.7%) |
| Dec 2020 | $28.19 M(+13.4%) | $28.19 M(-40.4%) |
| Sept 2020 | - | $47.27 M(-50.8%) |
| June 2020 | - | $96.05 M(+69.1%) |
| Mar 2020 | - | $56.79 M(+128.4%) |
| Dec 2019 | $24.87 M(-49.2%) | $24.87 M(-42.8%) |
| Sept 2019 | - | $43.46 M(+54.8%) |
| June 2019 | - | $28.08 M(-77.6%) |
| Mar 2019 | - | $125.57 M(+156.3%) |
| Dec 2018 | $48.99 M | $48.99 M(+17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $41.80 M(-6.6%) |
| June 2018 | - | $44.73 M(-31.8%) |
| Mar 2018 | - | $65.58 M(+184.5%) |
| Dec 2017 | $23.05 M(+119.7%) | $23.05 M(+0.2%) |
| Sept 2017 | - | $23.01 M(+142.0%) |
| June 2017 | - | $9.51 M(-30.5%) |
| Mar 2017 | - | $13.67 M(+30.3%) |
| Dec 2016 | $10.49 M(+36.2%) | $10.49 M(+53.9%) |
| Sept 2016 | - | $6.82 M(-45.0%) |
| June 2016 | - | $12.41 M(-41.4%) |
| Mar 2016 | - | $21.20 M(+175.1%) |
| Dec 2015 | $7.71 M(-33.5%) | $7.71 M(+15.2%) |
| Sept 2015 | - | $6.69 M(-42.8%) |
| June 2015 | - | $11.70 M(+7.9%) |
| Mar 2015 | - | $10.84 M(-6.4%) |
| Dec 2014 | $11.59 M(-52.5%) | $11.59 M(-29.2%) |
| Sept 2014 | - | $16.36 M(+104.4%) |
| June 2014 | - | $8.00 M(-64.2%) |
| Mar 2014 | - | $22.34 M(-8.4%) |
| Dec 2013 | $24.40 M(+215.8%) | $24.40 M |
| Dec 2012 | $7.73 M | - |
FAQ
- What is CymaBay Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CymaBay Therapeutics?
What is CymaBay Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CBAY is $206.53 M
What is the all time high annual cash & cash equivalents for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual cash & cash equivalents is $206.53 M
What is CymaBay Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CBAY is $206.53 M
What is the all time high quarterly cash and cash equivalents for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly cash and cash equivalents is $273.72 M